Loading
Journal of Diabetes and Clinical Research
ISSN: 2689-2839
Latest Articles
A Customized Artificial Pancreas System with Neural Network based Model Predictive Control for Type 1 Diabetic Rats
Omer Batuhan Kirilmaz , Masoud Mahdavi , Hoo Sang Ko , H. Felix Lee , Sarah Park , Guim Kwon
Advances in sensor and computing technology have enabled researchers to develop artificial pancreas systems (APS) that can mimic the glucose regulation function of a healthy pancreas to treat type 1 diabetes mellitus (T1DM). APS use a continuous glucose monitor (CGM) sensor to read the latest blood glucose level (BGL).
J Diabetes Clin Res, 2022, Volume 4, Issue 1, p1-9 | DOI: 10.33696/diabetes.4.049
A Machine Learning Study of 534,023 Medicare Beneficiaries with COVID-19: Implications for Personalized Risk Prediction for People Over 65
Chen Dun , Christi M. Walsh , Sunjae Bae , Amesh Adalja , Eric Toner , Timothy A. Lash , Farah Hashim , Joseph Paturzo , Dorry L. Segev , Martin A. Makary
The global outbreak of COVID-19 has resulted in over 378 million infections and worldwide deaths have surpassed 5.6 million. In the United States, there have been over 75 million confirmed cases and over 886,000 deaths as of February 1, 2022.
J Diabetes Clin Res, 2022, Volume 4, Issue 1, p10-16 | DOI: 10.33696/diabetes.4.050
Introducing m-Health and Digital Diabetes Apps in Clinical Pharmacy Education in Germany
Emina Obarcanin , Bushra Ali-Sherazi , Armin Dabidian , Sabina Schlottau , Maira Anna Deters , Stephanie Läer
Germany was the first country worldwide to implement German Digital Healthcare Act in 2019 to allow prescription and reimbursement of digital health applications (Digitale Gesundheitsanwendungen, DiGA). The German Federal Government has prioritized increased usage of mobile-Health (m-Health: use of mobile devices and digital technology in health care), recommending that physicians, other healthcare professionals, and patients work together to utilize the potential benefits of such technology.
J Diabetes Clin Res, 2022, Volume 4, Issue 1, p17-19 | DOI: 10.33696/diabetes.4.051
Sex Differences in Diabetic Ocular Surface Complications and Dysregulation of the OGF-OGFr Pathway
Ian S. Zagon , Joseph W. Sassani , Patricia J. McLaughlin
Diabetes is a chronic disorder that affects more than 500 million individuals worldwide. It is a life-long disease with complications that attack nearly all other systems within the body. Although there is a slight increase in the prevalence of diabetes in males, ocular surface complications are equally present in males and females.
J Diabetes Clin Res, 2022, Volume 4, Issue 1, p20-24 | DOI: 10.33696/diabetes.4.052